Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) )
ClinicalTrials.gov Identifier:
NCT00353860
First received: July 18, 2006
Last updated: November 4, 2014
Last verified: July 2014